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Key Points – Ebola Virus Disease, West Africa 
Updated August 19, 2014 
Newly updated information is indicated in red 
 
The Centers for Disease Control and Prevention (CDC) is working with other U.S. government 
agencies, the World Health Organization, and other domestic and international partners in an 
international response to the current Ebola outbreak in West Africa. This document 
summarizes key messages about the outbreak and the response. It will be updated as new 
information becomes available and distributed regularly. Please share the document with 
others as appropriate.          
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Summary Key Messages 
 This is the largest Ebola outbreak in history and the first in West Africa.  
 The outbreak in West Africa is worsening, but CDC, along with other U.S. government agencies 
and international partners, is taking steps to respond to this rapidly changing situation.  
 Ebola poses no substantial risk to the U.S. general population.    
 On August 8, the World Health Organization (WHO) declared that the current Ebola outbreak is 
a Public Health Emergency of International Concern (PHEIC).   
o The PHEIC declaration underscores the need for a coordinated international response to 
contain the spread of Ebola. 
o Information about the PHEIC declaration is available on the WHO website 
www.who.int/mediacentre/news/statements/2014/ebola-20140808/en/#.  
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 A person infected with Ebola virus is not contagious until symptoms appear.  
 The virus is spread through direct contact (through broken skin or unprotected mucous 
membranes in, for example, the eyes, nose, or mouth) with the blood or body fluids ( urine, 
feces, saliva, semen, and other secretions) of a person who is sick with Ebola, or with objects 
like needles that have been contaminated with the virus, or infected animals.  
o Ebola is not spread through the air or by water or, in general, by food; however, in 
Africa, Ebola may be spread as a result of hunting, processing, and consumption of 
infected animals (e.g., bushmeat). 
 As of August 19, no confirmed Ebola cases have been reported in the United States. 
o In 2014, two U.S. healthcare workers who were infected with Ebola virus in Liberia were 
transported to a hospital in the United States.  
o Other persons under investigation in the United States have all tested negative for 
Ebola. 
 As a precaution, CDC is communicating with American healthcare workers about how to detect 
and isolate patients who may have Ebola and how they can protect themselves from infection.  
 Early recognition of Ebola is important for providing appropriate patient care and preventing the 
spread of infection. Healthcare providers should be alert for and evaluate any patients who may 
have Ebola.  
o A case definition for Ebola virus disease is available at www.cdc.gov/vhf/ebola/hcp/case-
definition.html.    
 CDC and its partners at U.S. ports of entry are currently not doing enhanced screening of 
passengers traveling from the affected countries. However, CDC works with international public 
health organizations, other federal agencies, and the travel industry to identify sick travelers 
arriving in the United States and take public health actions to prevent the spread of 
communicable diseases.   
 CDC also is assisting with exit screening and communication efforts in West Africa to prevent 
sick travelers from getting on planes. 
 CDC recommends that people avoid nonessential travel to Guinea, Liberia, and Sierra Leone. 
 CDC recommends that people practice enhanced precautions if traveling to Nigeria. 
 Recommendations and guidance may change as new information becomes available.  
 
Ebola Cases and Deaths (West Africa) 
 As of August 16, 2014, a total of 2240 suspected and confirmed cases of Ebola and 1229 
deaths have been reported. 
o Guinea reported 543 cases, including 394 fatalities 
o Liberia reported 834 cases, including 466 fatalities 
o Nigeria reported 15 cases, including 4 fatalities 
o Sierra Leone reported 848 cases, including 365 fatalities 
 On July 25, the Nigerian Ministry of Health confirmed that a man in Lagos died 
from Ebola infection. The man had been in a hospital since arriving at the Lagos 
airport from Liberia. A small cluster of cases in Nigeria has been reported 
associated with this case, but there does not appear to be widespread 
transmission at this time. 
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 The death rate in some Ebola outbreaks has been as high as 90%. In this outbreak it is 
currently averaging around 55%-60% with variations in different areas that may be partly related 
to the availability of medical care. 
 For specific areas where cases have been identified, see CDC’s Ebola outbreak webpage 
(http://www.cdc.gov/vhf/ebola/outbreaks/guinea/index.html). 
 
Ebola in U.S. Healthcare Workers (in Liberia) 
 Two U.S. citizens working at a hospital in Monrovia, Liberia, were confirmed to have Ebola virus 
infection in late July.   
 Both patients were safely transported to a hospital in the United States. A CDC Health Alert 
Network (HAN) notice describing the report of the two American healthcare workers and 
providing guidance to U.S. healthcare workers and hospitals regarding Ebola virus disease was 
distributed by CDC on July 28 (http://emergency.cdc.gov/han/han00363.asp).     
 
Background on Ebola  
 Ebola, previously known as Ebola hemorrhagic fever, is a rare and deadly disease caused by 
infection with one of the Ebola virus strains (Zaire, Sudan, Bundibugyo, or Tai Forest virus). 
 Ebola viruses are found in several African countries. The first Ebola virus was discovered in 
1976 near the Ebola River in what is now the Democratic Republic of the Congo. Since then, 
outbreaks have appeared sporadically in Africa. 
 Based on evidence and the nature of other similar viruses, researchers believe that Ebola virus 
is animal-borne, with bats being the most likely reservoir. 
 Ebola is spread through direct contact (through broken skin or unprotected mucous membranes 
[e.g., eyes, nose, mouth]) with a sick person’s blood or body fluids, such as urine, saliva, feces, 
vomit, and semen. It is also spread through contact with contaminated objects (like syringes) or 
infected animals, for example, through processing of bushmeat. 
 The incubation period, from exposure to when signs or symptoms appear, ranges from 2 to 21 
days, with an average of 8 to 10 days. 
 Genetic analysis of the virus indicates it is closely related to variants of Ebola virus (species 
Zaire ebolavirus) identified earlier in the Democratic Republic of the Congo and Gabon. 
Symptoms 
 Signs of Ebola include fever (greater than 38.6°C or 101.5°F) and additional symptoms, such as 
severe headache, muscle pain, vomiting, diarrhea, abdominal pain, or unexplained hemorrhage. 
Risk 
 Healthcare providers caring for Ebola patients and the family and friends in close contact with 
Ebola patients are at the highest risk of getting sick because they may come in contact with the 
blood or body fluids of sick patients. 
o People also can become sick with Ebola after coming in contact with infected wildlife. 
For example, in Africa, Ebola may be spread as a result of hunting, processing of 
infected animals (e.g., bushmeat). 
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Prevention 
 There is no vaccine for Ebola.  
 If you must travel to an area affected by the Ebola outbreak, make sure to do the following: 
o Practice careful hygiene. Avoid contact with blood and body fluids. 
o Do not handle items that may have come in contact with an infected person’s blood or 
body fluids. 
o Avoid funeral or burial rituals that require handling the body of someone who has died 
from Ebola. 
o Avoid contact with bats and nonhuman primates or blood, fluids, and raw meat prepared 
from these animals. 
o Avoid hospitals where Ebola patients are being treated. The U.S. Embassy or consulate 
is often able to provide advice on healthcare facilities.  
o Seek medical care immediately if you develop fever, headache, muscle pain, diarrhea, 
vomiting, stomach pain, or unexplained bruising or bleeding. 
 Limit your contact with other people when you go to the doctor. Do not travel 
anywhere else. 
 After you return, pay attention to your health. 
o Monitor your health for 21 days if you were in an area with an Ebola outbreak, especially 
if you were in contact with blood or body fluids, items that have come in contact with 
blood or body fluids, animals or raw meat, or hospitals where Ebola patients are being 
treated or participated in burial rituals. 
o Seek medical care immediately if you develop fever, headache, muscle pain, diarrhea, 
vomiting, stomach pain, or unexplained bruising or bleeding.  
 Tell your doctor about your recent travel and your symptoms before you go to the 
office or emergency room. Advance notice will help your doctor care for you and 
protect other people who may be in the office. 
Treatment 
 No specific vaccine or medicine (e.g., antiviral drug) has been proven to be effective against 
Ebola.  
 Symptoms of Ebola are treated as they appear. The following basic interventions, when used 
early, can increase the chances of survival. 
o Providing intravenous fluids and balancing electrolytes (body salts) 
o Maintaining oxygen status and blood pressure 
o Treating other infections if they occur 
 Experimental treatments have been tested and proven effective in animals but have not yet 
been tested in humans. 
o ZMapp, developed by Mapp Biopharmaceutical Inc., is an experimental treatment for 
use with persons infected with Ebola virus. The product is a combination of three 
different monoclonal antibodies that bind to the protein of Ebola virus.  
o It is too early to know whether ZMapp is effective or not because the drug is still in an 
experimental stage and has not yet been tested in humans for safety or effectiveness. 
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Some patients infected with Ebola virus do get better spontaneously or with supportive 
care.  
 The best way to know if treatment with the product is effective is to conduct a 
randomized controlled clinical trial in people to compare outcomes of patients 
who receive the treatment to patients who have not. No such studies have been 
conducted to date. 
 
CDC Recommendations and Guidance 
Healthcare workers in West Africa 
Healthcare workers who may be exposed to people with Ebola should follow these steps: 
 Wear protective clothing, including masks, gloves, gowns, and eye protection. 
 Practice proper infection control and sterilization measures. For more information, see “Infection 
Control for Viral Hemorrhagic Fevers in the African Health Care Setting” 
(www.cdc.gov/vhf/abroad/vhf-manual.html).   
 Isolate patients with Ebola from other patients.  
 Avoid direct contact with the bodies of people who have died from Ebola. 
 Notify health officials if you have been exposed to someone with Ebola. 
Healthcare providers in the United States 
 CDC encourages all U.S. healthcare providers to 
o Ask patients about their travel histories to determine if they have traveled to West Africa 
within the last three weeks. 
o Know the signs and symptoms of Ebola – fever (greater than 38.6°C or 101.5°F) and 
additional symptoms, such as severe headache, muscle pain, vomiting, diarrhea, 
abdominal pain, or unexplained hemorrhage. 
o Know what to do if they have a patient with Ebola symptoms: 
 First, properly isolate the patient. 
 Then, follow infection control precautions to prevent the spread of Ebola. Avoid 
contact with blood and body fluids of infected people. 
 U.S. healthcare workers should follow CDC’s “Infection Prevention and Control 
Recommendations for Hospitalized Patients with Known or Suspected Ebola Hemorrhagic 
Fever in U.S. Hospitals” (www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-
recommendations.html).   
o CDC recommends standard, contact, and droplet precautions for management of 
hospitalized patients with known or suspected Ebola. These precautions can be found in 
“2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents 
in Healthcare Setting” at www.cdc.gov/hicpac/2007IP/2007ip_part3.html.   
Infection control 
 Any U.S. hospital that is following CDC's infection control recommendations and that can isolate a 
patient in their own room is capable of safely managing a patient with Ebola virus disease. 
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o These patients need intensive supportive care; any hospital that has this capability can 
safely manage these patients. 
o Standard, contact, and droplet precautions are recommended. 
 Early recognition 
o Early recognition is critical for infection control. Any patient with a suspected case of Ebola 
needs to be isolated until diagnosis is confirmed or Ebola is ruled out. 
o Healthcare providers should consider travel history, symptoms, and risks of exposure before 
recommending Ebola diagnosis.  
 Patient placement 
o Patients should be placed in a single patient room (containing a private bathroom) with the 
door closed.   
o Facilities should maintain a log of all persons entering the patient’s room 
 Protecting healthcare providers 
o All persons entering the patient room should wear at least: gloves, gown (fluid resistant or 
impermeable), eye protection (goggles or face shield), and a facemask 
o Additional personal protective equipment (PPE) might be required in certain situations (e.g., 
copious amounts of blood, other body fluids, vomit, or feces present in the environment), 
including but not limited to double gloving, disposable shoe covers, and leg coverings 
o Healthcare providers should frequently perform hand hygiene before and after all patient 
contact, contact with potentially infectious material, and before putting on and upon removal 
of PPE, including gloves. 
 Patient care equipment 
o Dedicated medical equipment (preferably disposable, when possible) should be used for the 
provision of patient care. 
o All non-dedicated, non-disposable medical equipment used for patient care should be 
cleaned and disinfected according to the manufacturer's instructions and hospital policies. 
 Patient care considerations 
o Limit the use of needles and other sharps as much as possible. 
o Phlebotomy, procedures, and laboratory testing should be limited to the minimum necessary 
for essential diagnostic evaluation and medical care. 
o All needles and sharps should be handled with extreme care and disposed in puncture-
proof, sealed containers 
o Avoid aerosol-generating procedures. If performing aerosol-generating procedures, use a 
combination of measures to reduce exposures from patients with Ebola hemorrhagic fever. 
(See CDC’s guidance for more details on how to perform aerosol generating procedures 
safely: www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-recommendations.html.)  
 Environmental infection control 
o Diligent environmental cleaning and disinfection and safe handling of potentially 
contaminated materials is paramount, as blood, sweat, emesis, feces, and other body 
secretions represent potentially infectious materials. 
o Healthcare providers performing environmental cleaning and disinfection should wear 
recommended PPE (described above) and consider use of additional barriers (e.g., shoe 
and leg coverings) if needed. 
o Face protection (face shield or mask with goggles) should be worn when performing tasks 
such as liquid waste disposal that can generate splashes. 
8/19/2014  FOR EXTERNAL DISTRIBUTION 
 
7 
Prepared by the Joint Information Center, Emergency Operations Center, Centers for Disease Control and Prevention 
o Follow standard procedures, per hospital policy and manufacturers’ instructions, for cleaning 
and/or disinfection of:  
 Environmental surfaces and equipment  
 Textiles and laundry 
 Food utensils and dishware 
 Duration of precautions 
o The duration of precautions should be determined on a case-by-case basis, in conjunction 
with local, state, and federal health authorities. 
 For more details on infection control in U.S. hospitals, see www.cdc.gov/vhf/ebola/hcp/infection-
prevention-and-control-recommendations.html.  
Travelers  
 CDC has issued a Warning, Level 3 travel notice for 3 countries. U.S. citizens should avoid all 
nonessential travel to Guinea, Liberia, and Sierra Leone. 
 CDC has issued an Alert, Level 2 travel notice for Nigeria. Travelers to Nigeria should take 
enhanced precautions to prevent Ebola.   
 If you travel to any of the four affected countries, make sure to do the following: 
o Practice careful hygiene. Avoid contact with blood and body fluids. 
o Do not handle items that may have come in contact with an infected person’s blood or 
body fluids. 
o Avoid funeral or burial rituals that require handling the body of someone who has died 
from Ebola. 
o Avoid contact with animals or raw meat. 
o Avoid hospitals where patients with Ebola are being treated. The U.S. Embassy or 
consulate is often able to provide advice on facilities.  
o Seek medical care immediately if you develop fever, headache, muscle aches, diarrhea, 
vomiting, stomach pain, or unexplained bruising or bleeding. 
 Limit your contact with other people when you go to the doctor. Do not travel 
anywhere else. 
o Pay attention to your health after you return. 
 Monitor your health for 21 days if you were in an area with an Ebola outbreak, 
especially if you were in contact with blood or body fluids, items that have come 
in contact with blood or body fluids, animals or raw meat, or hospitals where 
patients with Ebola are being treated.  
 Seek medical care immediately if you develop fever, headache, muscle pain, 
diarrhea, vomiting, stomach pain, or unexplained bruising or bleeding.  
 Tell your doctor about your recent travel and your symptoms before you 
go to the office or emergency room. Advance notice will help your doctor 
care for you and protect other people who may be in the office. 
 Visit the CDC Travelers’ Health website (www.cdc.gov/travel/) for more information about the 
outbreak and for other health recommendations to the specific countries. 
Airline flight crews, cleaning personnel, and cargo personnel 
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 CDC’s Interim Guidance about Ebola Virus Infection for Airline Flight Crews, Cleaning 
Personnel, and Cargo Personnel is posted on CDC’s website at 
www.cdc.gov/quarantine/air/managing-sick-travelers/ebola-guidance-airlines.html.  
Monitoring and movement of people with Ebola 
 CDC has developed interim guidance to provide public health authorities and other partners a 
framework for evaluating people’s risk of exposure to Ebola and initiating appropriate public 
health actions on the basis of exposure risk and clinical assessment.  
 The interim guidance describes public health actions for people with high risk, low risk, and no 
known exposure to Ebola. The guidance is available on CDC’s website 
www.cdc.gov/vhf/ebola/hcp/monitoring-and-movement-of-persons-with-exposure.html.   
Laboratories 
 CDC recommends that healthcare workers contact their state and/or local health department 
and CDC to determine the proper category for shipment based on clinical history and risk 
assessment by CDC. 
o State guidelines may differ and state or local health departments should be consulted 
before shipping.  
o For updated guidance on specimen submission, see 
www.cdc.gov/ncezid/dhcpp/vspb/specimens.html 
o CDC has developed interim guidance for laboratorians and other healthcare personnel 
who collect or handle specimens in the United States on the appropriate steps for 
collecting, transporting, and testing specimens from patients who are suspected to be 
infected with Ebola virus. The guidance is available on CDC’s website 
www.cdc.gov/vhf/ebola/hcp/interim-guidance-specimen-collection-submission-patients-
suspected-infection-ebola.html.    
 Ebola virus is detected in blood only after onset of symptoms, most notably fever.  
o It may take up to 3 days post-onset of symptoms for the virus to reach detectable levels.  
o Virus is generally detectable by real-time RT-PCR between 3 to 10 days post-onset of 
symptoms, but has been detected for several months in certain secretions (e.g., semen).  
o Specimens ideally should be taken when a symptomatic patient reports to a healthcare 
facility and is suspected of having an Ebola exposure; however, if the onset of symptoms 
is less than 3 days, a subsequent specimen will be required to completely rule-out 
Ebola. 
What CDC is Doing 
 CDC has activated its Emergency Operations Center (EOC) to help coordinate technical 
assistance and control activities with partners.  
o On August 6, CDC elevated the EOC to a Level 1 activation, its highest level, because of 
the significance of the outbreak.  
o CDC is in regular communication with other U.S. government agencies that are 
participating in the response, the ministries of health of the affected countries, the World 
Health Organization (WHO), and other international partners. 
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 CDC has deployed several teams of public health experts to the West Africa region. As of 
August 19, 60 CDC staff deployed in Guinea, Liberia, Nigeria, and Sierra Leone are assisting 
with various response efforts, including surveillance, contact tracing, database management, 
and health education.  
o Over the next month, CDC plans to send additional public health experts to the affected 
countries to expand current response activities.  
o CDC staff are assisting with setting up an emergency response structure, contact 
tracing, providing advice on exit screening and infection control at major airports, and 
providing training and education in the affected countries. 
o As of August 19, nine health communicators have been deployed to Guinea, Liberia, and 
Sierra Leone.  
 CDC is working closely with U.S. Agency for International Development (USAID), Office of 
Foreign Disaster Assistance (OFDA), on deployment of a Disaster Assistance Response Team 
(DART), which is overseeing the U.S. government’s Ebola response in West Africa.   
o During the weekend of August 16, CDC shipped a mobile testing laboratory from Atlanta 
to Liberia to increase the number of specimens being tested for Ebola.  
 CDC has issued a Warning, Level 3 notice for U.S. citizens to avoid nonessential travel to the 
West African nations of Guinea (http://wwwnc.cdc.gov/travel/notices/warning/ebola-guinea), 
Liberia (http://wwwnc.cdc.gov/travel/notices/warning/ebola-liberia), and Sierra Leone 
(http://wwwnc.cdc.gov/travel/notices/warning/ebola-sierra-leone). CDC also has issued an Alert, 
Level 2 travel notice to advise about enhanced precautions for people traveling to Nigeria 
(http://wwwnc.cdc.gov/travel/notices/alert/ebola-nigeria).   
o At this time, CDC is not doing enhanced screening of arriving travelers at U.S. airports, 
seaports, or land borders.  
o CDC is working closely with Customs and Border Protection (CBP) and other partners at 
ports of entry (primarily international airports) to use routine processes to identify 
travelers who show signs of infectious disease. In response to the outbreak, these 
processes have been enhanced through guidance and training. CDC’s quarantine 
station staff are asked to respond as needed, for example by evaluating ill travelers 
identified by CBP officers. 
 If an ill traveler is identified during or after a flight, CDC will conduct an 
investigation of exposed travelers and work with the airline, federal partners, and 
state and local health departments to notify them and take any necessary public 
health action. 
o CDC is assisting with exit screening and communication efforts in West Africa to prevent 
sick travelers from getting on planes. 
o CDC has released interim guidance for airline flight crews, cleaning personnel, and 
cargo personnel that can be found at www.cdc.gov/quarantine/air/managing-sick-
travelers/ebola-guidance-airlines.html.  
o CDC has developed and posted Ebola-specific travel messages for electronic monitors 
to reach travelers from West Africa and posters for TSA screening areas of airports to 
reach outbound travelers. Visit wwwnc.cdc.gov/travel/page/infographics-travelers to see 
the messages.  
 CDC is actively working to educate American healthcare workers on how to isolate patients and 
how to protect themselves from infection. 
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o On August 1, CDC sent out a Health Alert Network (HAN) advisory 
(www.bt.cdc.gov/han/han00364.asp) informing U.S. healthcare workers of guidelines for 
evaluating U.S. patients suspected of having Ebola.  
o CDC has developed guidance for U.S. healthcare providers outlining how to prevent and 
control infections in hospitalized patients with known or suspected Ebola. This guidance 
can be found at www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-
recommendations.html.  
o On July 28, CDC sent out a HAN advisory (http://emergency.cdc.gov/han/han00363.asp) 
urging U.S. healthcare workers to be alert for signs and symptoms of Ebola in patients 
who have a recent travel history to countries where the outbreak is occurring.  
 CDC continues to update its communication products and webpages with new information on 
the Ebola outbreak for the general public and specific audiences.  
o A Questions and Answers on Ebola document 
(www.cdc.gov/vhf/ebola/outbreaks/guinea/qa.html) was posted on CDC’s Ebola website 
and will be updated regularly. 
o CDC is working with partners to display Ebola-specific travel messages for electronic 
monitors and posters at ports of entry to reach travelers from West Africa.  
 CDC is using social media as a way to share credible, fact-based information and to dispel 
misconceptions about Ebola. 
o CDC hosted a Twitter chat about Ebola and the current outbreak on August 4. The chat 
was the largest chat in CDC history and provided the public an opportunity to have direct 
access to CDC’s disease detectives. The potential reach of the chat was over 109 
million. 
Stigma 
West Africans in the United States and elsewhere may face stigmatization (stigma) during the current 
Ebola outbreak because the outbreak is associated with a region of the world. 
 
 Stigma involves stereotyping and discriminating against an identifiable group of people, a 
product, an animal, a place, or a nation.  
o Stigma can occur when people associate an infectious disease, such as Ebola, with a 
population, even though not everyone in that population or from that region is 
specifically at risk for the disease (for example, West Africans living in the United 
States).   
o Stigma occurred among Asian Americans in the United States during the SARS 
pandemic in 2003.    
 Communicators and public health officials can help counter stigma during the Ebola 
response.   
o Communicate early the risk or lack of risk from associations with products, 
people, and places.  
o Raise awareness of the potential problem.  
o Counter stigmatization with accurate risk information about how the virus 
spreads.  
o Speak out against negative behaviors.   
o Be cautious about the images that are shared. Make sure they do not reinforce 
stereotypes. 
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o Model good behaviors; engage with stigmatized groups in person and through 
social media.   
 
For More Information about Ebola 
 CDC will continue to post new information about the Ebola outbreak on the following websites 
as it becomes available: 
o CDC Ebola Hemorrhagic Fever site: www.cdc.gov/ebola  
o CDC Travelers’ Health site: http://wwwnc.cdc.gov/travel/notices 
 World Health Organization (WHO) Ebola virus disease (EVD) site: 
www.who.int/csr/disease/ebola/en/  
